Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and ...

Making treatment for non–small cell lung cancer (NSCLC) accessible to a wide range of the population can help to improve ...

US adults who were displaced and never returned home due to a natural disaster had the highest odds of developing depression or anxiety.

A new study finds that drugmakers’ use of overlapping patents delayed generic entry for 4 top-selling drugs, driving billions in excess spending.

The humanized IgG4 monoclonal antibody was first approved for myasthenia gravis in the US in 2023, with approvals in Japan ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

James Chalmers, MBChB, PhD, highlights the reassuring safety and tolerability profile of brensocatib in patients with non–cystic fibrosis bronchiectasis.

Panelists discuss the challenges of biologic access in hidradenitis suppurativa due to utilization management policies like step therapy, emphasizing the need for patient education, strategic planning ...

Panelists discuss the anticipated 2026 updates to the American Academy of Dermatology guidelines for hidradenitis suppurativa, highlighting efforts to unify treatment protocols, support biologic ...

Patients with alopecia universalis and alopecia totalis are at a particularly high risk of cardiovascular disease, a new ...

New drugs aren't the only advances in oncology. Innovation includes collaboration between to remove barriers to remove ...

Emerging data suggest that isatuximab‐KRd and daratumumab‐KRd produce superior depth of response compared with KRd alone, with sustained MRD negativity and encouraging progression‐free survival in ...